KBLB - Kraig Biocraft Laboratories, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
402
97
32
0
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
144
148
259
397
432
Selling General and Administrative
2,093
1,213
1,994
2,580
1,623
Total Operating Expenses
2,237
1,362
2,253
2,977
2,055
Operating Income or Loss
-2,237
-960
-2,156
-2,946
-2,055
Interest Expense
273
229
177
139
102
Total Other Income/Expenses Net
-
20
-
11
22
Income Before Tax
-2,503
-1,169
-2,333
-3,074
-2,134
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-2,503
-1,169
-2,333
-3,074
-2,134
Net Income
-2,503
-1,169
-2,333
-3,074
-2,134
Net Income available to common shareholders
-2,503
-1,169
-2,333
-3,074
-2,134
Reported EPS
Basic
-
-0.00
-0.00
-0.00
-0.00
Diluted
-
-0.00
-0.00
-0.00
-0.00
Weighted average shares outstanding
Basic
-
816,874
791,393
744,284
685,837
Diluted
-
816,874
791,393
744,284
685,837
EBITDA
-
-913
-2,136
-2,917
-2,017